Literature DB >> 19414671

Toward noninvasive genomic screening of lung cancer patients.

Lecia V Sequist, Jeffrey A Engelman, Thomas J Lynch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19414671     DOI： 10.1200/JCO.2008.20.4875

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.

Authors:  Maria D Lozano; Javier J Zulueta; Jose I Echeveste; Alfonso Gúrpide; Luis M Seijo; Salvador Martín-Algarra; Anabel Del Barrio; Ruben Pio; Miguel Angel Idoate; Tania Labiano; Jose Luis Perez-Gracia
Journal:  Oncologist       Date:  2011-05-14

2.  Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.

Authors:  K L Aung; R E Board; G Ellison; E Donald; T Ward; G Clack; M Ranson; A Hughes; W Newman; C Dive
Journal:  Hugo J       Date:  2011-01-30

3.  Survival and death signals can predict tumor response to therapy after oncogene inactivation.

Authors:  Phuoc T Tran; Pavan K Bendapudi; H Jill Lin; Peter Choi; Shan Koh; Joy Chen; George Horng; Nicholas P Hughes; Lawrence H Schwartz; Vincent A Miller; Toshiyuki Kawashima; Toshio Kitamura; David Paik; Dean W Felsher
Journal:  Sci Transl Med       Date:  2011-10-05       Impact factor: 17.956

4.  Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

Authors:  Raymond H Mak; Subba R Digumarthy; Alona Muzikansky; Jeffrey A Engelman; Jo-Anne O Shepard; Noah C Choi; Lecia V Sequist
Journal:  Oncologist       Date:  2011-02-21

5.  Personalized medicine and inhibition of EGFR signaling in lung cancer.

Authors:  Adi F Gazdar
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245

Review 6.  Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer.

Authors:  Kah Weng Lau; Claudia Seng; Tony K H Lim; Daniel S W Tan
Journal:  Ann Transl Med       Date:  2017-09

7.  Lung Cancer: Are we up to the Challenge?

Authors:  Luca Esposito; Daniele Conti; Ramyasri Ailavajhala; Nansie Khalil; Antonio Giordano
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

8.  Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma.

Authors:  Irene Centeno; Pilar Blay; Iñigo Santamaría; Aurora Astudillo; Ana S Pitiot; Fernando G Osorio; Patricia González-Arriaga; Fernando Iglesias; Primitiva Menéndez; Adonina Tardón; Jose M Freije; Milagros Balbín
Journal:  BMC Cancer       Date:  2011-05-16       Impact factor: 4.430

Review 9.  [The detection methods of EGFR mutations in non-small cell lung cancer].

Authors:  Xinyu Zhang; Guiyang Liu; Xiaoguang Zhu; Weilan Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.